Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""PULMONARY fibrosis"" wg kryterium: Temat


Tytuł :
Pulmonary Stretch and Lung Mechanotransduction: Implications for Progression in the Fibrotic Lung.
Autorzy :
Marchioni A; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41125 Modena, Italy.; University Hospital of Modena, Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University of Modena Reggio Emilia, 41125 Modena, Italy.
Tonelli R; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41125 Modena, Italy.; University Hospital of Modena, Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University of Modena Reggio Emilia, 41125 Modena, Italy.; Clinical and Experimental Medicine PhD Program, University of Modena Reggio Emilia, 41125 Modena, Italy.
Cerri S; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41125 Modena, Italy.; University Hospital of Modena, Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University of Modena Reggio Emilia, 41125 Modena, Italy.
Castaniere I; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41125 Modena, Italy.; University Hospital of Modena, Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University of Modena Reggio Emilia, 41125 Modena, Italy.
Andrisani D; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41125 Modena, Italy.; University Hospital of Modena, Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University of Modena Reggio Emilia, 41125 Modena, Italy.; Clinical and Experimental Medicine PhD Program, University of Modena Reggio Emilia, 41125 Modena, Italy.
Gozzi F; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41125 Modena, Italy.; University Hospital of Modena, Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University of Modena Reggio Emilia, 41125 Modena, Italy.; Clinical and Experimental Medicine PhD Program, University of Modena Reggio Emilia, 41125 Modena, Italy.
Bruzzi G; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41125 Modena, Italy.; University Hospital of Modena, Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University of Modena Reggio Emilia, 41125 Modena, Italy.
Manicardi L; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41125 Modena, Italy.; University Hospital of Modena, Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University of Modena Reggio Emilia, 41125 Modena, Italy.
Moretti A; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41125 Modena, Italy.; University Hospital of Modena, Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University of Modena Reggio Emilia, 41125 Modena, Italy.
Demurtas J; Primary Care Department USL Toscana Sud Est-Grosseto, 58100 Grosseto, Italy.
Baroncini S; University Hospital of Modena, Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University of Modena Reggio Emilia, 41125 Modena, Italy.
Andreani A; University Hospital of Modena, Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University of Modena Reggio Emilia, 41125 Modena, Italy.
Cappiello GF; University Hospital of Modena, Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University of Modena Reggio Emilia, 41125 Modena, Italy.
Busani S; University Hospital of Modena, Anesthesiology Unit, University of Modena Reggio Emilia, 41124 Modena, Italy.
Fantini R; University Hospital of Modena, Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University of Modena Reggio Emilia, 41125 Modena, Italy.
Tabbì L; University Hospital of Modena, Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University of Modena Reggio Emilia, 41125 Modena, Italy.
Samarelli AV; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41125 Modena, Italy.; University Hospital of Modena, Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University of Modena Reggio Emilia, 41125 Modena, Italy.
Clini E; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41125 Modena, Italy.; University Hospital of Modena, Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University of Modena Reggio Emilia, 41125 Modena, Italy.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Jun 16; Vol. 22 (12). Date of Electronic Publication: 2021 Jun 16.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Elasticity*
Mechanotransduction, Cellular*
Lung/*metabolism
Lung/*pathology
Pulmonary Fibrosis/*metabolism
Pulmonary Fibrosis/*pathology
Algorithms ; Alveolar Epithelial Cells/metabolism ; Alveolar Epithelial Cells/pathology ; Animals ; Disease Progression ; Disease Susceptibility ; Extracellular Matrix/metabolism ; Extracellular Matrix/pathology ; Humans ; Idiopathic Pulmonary Fibrosis/etiology ; Idiopathic Pulmonary Fibrosis/metabolism ; Idiopathic Pulmonary Fibrosis/pathology ; Mechanical Phenomena ; Models, Biological ; Pulmonary Fibrosis/etiology
Czasopismo naukowe
Tytuł :
Citrus Alkaline Extracts Inhibit Senescence of A549 Cells to Alleviate Pulmonary Fibrosis via the β-Catenin/P53 Pathway.
Autorzy :
Han D; Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China (mainland).
Xu Y; Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China (mainland).
Peng WP; Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China (mainland).
Feng F; Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China (mainland).; Department of Respiratory Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China (mainland).
Wang Z; Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China (mainland).
Gu C; Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China (mainland).
Zhou X; Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China (mainland).; Department of Respiratory Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China (mainland).
Pokaż więcej
Źródło :
Medical science monitor : international medical journal of experimental and clinical research [Med Sci Monit] 2021 Mar 12; Vol. 27, pp. e928547. Date of Electronic Publication: 2021 Mar 12.
Typ publikacji :
Journal Article
MeSH Terms :
Alveolar Epithelial Cells/*metabolism
Citrus/*metabolism
Idiopathic Pulmonary Fibrosis/*metabolism
A549 Cells ; Aging/drug effects ; Aging/physiology ; Alveolar Epithelial Cells/drug effects ; Cellular Senescence/drug effects ; Cellular Senescence/physiology ; China ; Doxorubicin/adverse effects ; Doxorubicin/pharmacology ; Fibroblasts/metabolism ; Humans ; Idiopathic Pulmonary Fibrosis/drug therapy ; Lung/metabolism ; Plant Extracts/pharmacology ; Pulmonary Fibrosis/metabolism ; Tumor Suppressor Protein p53/metabolism ; beta Catenin/metabolism
Czasopismo naukowe
Tytuł :
Uniportal video-assisted thoracic surgery and perioperative pirfenidone for lung cancer and idiopathic pulmonary fibrosis: a case report.
Autorzy :
Saiki A; Department of General Thoracic Surgery, Social Welfare Organization Saiseikai Imperial Gift Foundation, Chibaken Saiseikai Narashino Hospital, Chiba, Japan.; Department of Respiratory Medicine, Social Welfare Organization Saiseikai Imperial Gift Foundation, Chibaken Saiseikai Narashino Hospital, Chiba, Japan.
Mizobuchi T; Department of General Thoracic Surgery, Social Welfare Organization Saiseikai Imperial Gift Foundation, Chibaken Saiseikai Narashino Hospital, Chiba, Japan.
Nagato K; Department of General Thoracic Surgery, Social Welfare Organization Saiseikai Imperial Gift Foundation, Chibaken Saiseikai Narashino Hospital, Chiba, Japan.
Ishibashi F; Department of General Thoracic Surgery, Social Welfare Organization Saiseikai Imperial Gift Foundation, Chibaken Saiseikai Narashino Hospital, Chiba, Japan.
Tsuyusaki J; Department of Respiratory Medicine, Social Welfare Organization Saiseikai Imperial Gift Foundation, Chibaken Saiseikai Narashino Hospital, Chiba, Japan.
Sugano I; Department of Pathology, Social Welfare Organization Saiseikai Imperial Gift Foundation, Chibaken Saiseikai Narashino Hospital, Chiba, Japan.
Pokaż więcej
Źródło :
The Journal of international medical research [J Int Med Res] 2021 Sep; Vol. 49 (9), pp. 3000605211016998.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Idiopathic Pulmonary Fibrosis*/diagnostic imaging
Idiopathic Pulmonary Fibrosis*/drug therapy
Idiopathic Pulmonary Fibrosis*/surgery
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/drug therapy
Lung Neoplasms*/surgery
Aged ; Female ; Humans ; Neoplasm Recurrence, Local ; Pyridones ; Thoracic Surgery, Video-Assisted
Czasopismo naukowe
Tytuł :
Cross-species integration of single-cell RNA-seq resolved alveolar-epithelial transitional states in idiopathic pulmonary fibrosis.
Autorzy :
Huang KY; Program in Cardiovascular and Metabolic Disorders (CVMD) and Center for Computational Biology (CCB), Duke-NUS Medical School, Singapore, Republic of Singapore.
Petretto E; Program in Cardiovascular and Metabolic Disorders (CVMD) and Center for Computational Biology (CCB), Duke-NUS Medical School, Singapore, Republic of Singapore.
Pokaż więcej
Źródło :
American journal of physiology. Lung cellular and molecular physiology [Am J Physiol Lung Cell Mol Physiol] 2021 Sep 01; Vol. 321 (3), pp. L491-L506. Date of Electronic Publication: 2021 Jun 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Gene Expression Regulation*
Idiopathic Pulmonary Fibrosis*/genetics
Idiopathic Pulmonary Fibrosis*/metabolism
Idiopathic Pulmonary Fibrosis*/pathology
RNA-Seq*
Single-Cell Analysis*
Alveolar Epithelial Cells/*metabolism
Respiratory Mucosa/*metabolism
Alveolar Epithelial Cells/pathology ; Animals ; Disease Models, Animal ; Humans ; Mice ; Mice, Knockout ; Respiratory Mucosa/pathology ; Species Specificity
Czasopismo naukowe
Tytuł :
CircRNA_0026344 via exosomal miR-21 regulation of Smad7 is involved in aberrant cross-talk of epithelium-fibroblasts during cigarette smoke-induced pulmonary fibrosis.
Autorzy :
Bai J; School of Public Health, Southwest Medical University, Luzhou, 646000, Sichuan, People's Republic of China.
Deng J; Department of Clinical Laboratory, 404 Hospital of Mianyang, Mianyang, 621000, Sichuan, People's Republic of China.
Han Z; School of Public Health, Southwest Medical University, Luzhou, 646000, Sichuan, People's Republic of China.
Cui Y; School of Public Health, Southwest Medical University, Luzhou, 646000, Sichuan, People's Republic of China.
He R; School of Public Health, Southwest Medical University, Luzhou, 646000, Sichuan, People's Republic of China.
Gu Y; Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, 646000, Sichuan, People's Republic of China. Electronic address: .
Zhang Q; School of Public Health, Southwest Medical University, Luzhou, 646000, Sichuan, People's Republic of China. Electronic address: .
Pokaż więcej
Źródło :
Toxicology letters [Toxicol Lett] 2021 Sep 01; Vol. 347, pp. 58-66. Date of Electronic Publication: 2021 May 04.
Typ publikacji :
Journal Article
MeSH Terms :
Cell Communication*
Epithelial Cells/*metabolism
Exosomes/*metabolism
Fibroblasts/*metabolism
Lung/*metabolism
Pulmonary Fibrosis/*metabolism
RNA, Circular/*metabolism
Smad7 Protein/*metabolism
Animals ; Cell Line ; Disease Models, Animal ; Epithelial Cells/pathology ; Exosomes/genetics ; Exosomes/pathology ; Fibroblasts/pathology ; Gene Expression Regulation ; Humans ; Lung/pathology ; Male ; Mice, Inbred BALB C ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Pulmonary Fibrosis/etiology ; Pulmonary Fibrosis/genetics ; Pulmonary Fibrosis/pathology ; RNA, Circular/genetics ; Signal Transduction ; Smad7 Protein/genetics ; Smoke ; Tobacco Products ; Transforming Growth Factor beta1/metabolism
Czasopismo naukowe
Tytuł :
Diagnosis and Management of Idiopathic Pulmonary Fibrosis.
Autorzy :
Munchel JK; Division of Pulmonary, Critical Care and Sleep Medicine; Rhode Island Hospital and Alpert Medical School of Brown University; Providence, RI.
Shea BS; Division of Pulmonary, Critical Care and Sleep Medicine; Rhode Island Hospital and Alpert Medical School of Brown University; Providence, RI.
Pokaż więcej
Źródło :
Rhode Island medical journal (2013) [R I Med J (2013)] 2021 Sep 01; Vol. 104 (7), pp. 26-29. Date of Electronic Publication: 2021 Sep 01.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Idiopathic Pulmonary Fibrosis*/diagnostic imaging
Idiopathic Pulmonary Fibrosis*/therapy
Lung Diseases, Interstitial*/diagnosis
Biopsy ; Diagnosis, Differential ; Humans ; Lung/diagnostic imaging ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
The protective potential of alpha lipoic acid on amiodarone-induced pulmonary fibrosis and hepatic injury in rats.
Autorzy :
Ibrahim Fouad G; Department of Therapeutic Chemistry, National Research Centre, 33 El-Bohouth St., Dokki, Cairo, 12622, Egypt. .
R Mousa M; Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Giza, 12211, Egypt.
Pokaż więcej
Źródło :
Molecular and cellular biochemistry [Mol Cell Biochem] 2021 Sep; Vol. 476 (9), pp. 3433-3448. Date of Electronic Publication: 2021 May 10.
Typ publikacji :
Journal Article
MeSH Terms :
Amiodarone/*toxicity
Antioxidants/*pharmacology
Chemical and Drug Induced Liver Injury/*prevention & control
Protective Agents/*pharmacology
Pulmonary Fibrosis/*prevention & control
Thioctic Acid/*pharmacology
Alanine Transaminase/metabolism ; Animals ; Chemical and Drug Induced Liver Injury/etiology ; Chemical and Drug Induced Liver Injury/metabolism ; Chemical and Drug Induced Liver Injury/pathology ; Cytokines/metabolism ; Glutathione/metabolism ; Inflammation Mediators/metabolism ; Male ; Malondialdehyde/metabolism ; Oxidative Stress ; Pulmonary Fibrosis/chemically induced ; Pulmonary Fibrosis/metabolism ; Pulmonary Fibrosis/pathology ; Rats ; Rats, Wistar ; Vasodilator Agents/toxicity
Czasopismo naukowe
Tytuł :
Spatially Resolved Identification of Transglutaminase Substrates by Proteomics in Pulmonary Fibrosis.
Autorzy :
Takeuchi T; Cellular Biochemistry Laboratory, Graduate School of Pharmaceutical Sciences, and.
Tatsukawa H; Cellular Biochemistry Laboratory, Graduate School of Pharmaceutical Sciences, and.
Shinoda Y; Cellular Biochemistry Laboratory, Graduate School of Pharmaceutical Sciences, and.
Kuwata K; Institute of Transformative Bio-Molecules, Nagoya University, Tokai National Higher Education and Research System, Furo-cho, Chikusa, Nagoya, Japan; and.
Nishiga M; Teijin Institute for Bio-Medical Research, Teijin Pharma Limited, Hino, Tokyo, Japan.
Takahashi H; Teijin Institute for Bio-Medical Research, Teijin Pharma Limited, Hino, Tokyo, Japan.
Hase N; Teijin Institute for Bio-Medical Research, Teijin Pharma Limited, Hino, Tokyo, Japan.
Hitomi K; Cellular Biochemistry Laboratory, Graduate School of Pharmaceutical Sciences, and.
Pokaż więcej
Źródło :
American journal of respiratory cell and molecular biology [Am J Respir Cell Mol Biol] 2021 Sep; Vol. 65 (3), pp. 319-330.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Proteomics*
Signal Transduction*
GTP-Binding Proteins/*metabolism
Lung/*enzymology
Pulmonary Fibrosis/*epidemiology
Transglutaminases/*metabolism
Animals ; Lung/pathology ; Mice ; Pulmonary Fibrosis/chemically induced ; Pulmonary Fibrosis/pathology
Czasopismo naukowe
Tytuł :
Dysbalance of ACE2 levels - a possible cause for severe COVID-19 outcome in COPD.
Autorzy :
Fließer E; Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
Birnhuber A; Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
Marsh LM; Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
Gschwandtner E; Division of Thoracic Surgery, Department of Surgery, Medical University of Vienna, Vienna, Austria.
Klepetko W; Division of Thoracic Surgery, Department of Surgery, Medical University of Vienna, Vienna, Austria.
Olschewski H; Division of Pulmonology, Medical University of Graz, Graz, Austria.
Kwapiszewska G; Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.; Otto Loewi Research Center, Medical University of Graz, Graz, Austria.
Pokaż więcej
Źródło :
The journal of pathology. Clinical research [J Pathol Clin Res] 2021 Sep; Vol. 7 (5), pp. 446-458. Date of Electronic Publication: 2021 May 12.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Angiotensin-Converting Enzyme 2/*metabolism
COVID-19/*pathology
Familial Primary Pulmonary Hypertension/*pathology
Idiopathic Pulmonary Fibrosis/*pathology
Pulmonary Disease, Chronic Obstructive/*pathology
SARS-CoV-2/*physiology
Serine Endopeptidases/*metabolism
Adult ; Aged ; Angiotensin-Converting Enzyme 2/genetics ; Basigin/genetics ; Basigin/metabolism ; COVID-19/metabolism ; COVID-19/virology ; Disease Susceptibility ; Familial Primary Pulmonary Hypertension/enzymology ; Familial Primary Pulmonary Hypertension/virology ; Female ; Furin/genetics ; Furin/metabolism ; Gene Expression Regulation ; Humans ; Idiopathic Pulmonary Fibrosis/metabolism ; Idiopathic Pulmonary Fibrosis/virology ; Lung/metabolism ; Lung/pathology ; Lung/virology ; Male ; Middle Aged ; Pulmonary Disease, Chronic Obstructive/metabolism ; Pulmonary Disease, Chronic Obstructive/virology ; Risk Factors ; Serine Endopeptidases/genetics ; Virus Internalization
Czasopismo naukowe
Tytuł :
Effectivity of mesenchymal stem cells for bleomycin-induced pulmonary fibrosis: a systematic review and implication for clinical application.
Autorzy :
Zhao Y; Department of Infectious Diseases, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 Xi Wu Road, Xi'an, 710004, Shaanxi, China.
Yan Z; Department of Liver Diseases, The Hospital Affiliated to Shaanxi University of Chinese Medicine, Xianyang, 712046, China.
Liu Y; The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, China.
Zhang Y; The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, China.
Shi J; Department of Respiratory, The Hospital Affiliated to Shaanxi University of Chinese Medicine, Xianyang, China.
Li J; Department of Liver Diseases, The Hospital Affiliated to Shaanxi University of Chinese Medicine, Xianyang, 712046, China. .
Ji F; Department of Infectious Diseases, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 Xi Wu Road, Xi'an, 710004, Shaanxi, China. .; National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. .; Key Laboratory of Environment and Genes Related To Diseases, Xi'an Jiaotong University, Ministry of Education of China, Xi'an, China. .
Pokaż więcej
Źródło :
Stem cell research & therapy [Stem Cell Res Ther] 2021 Aug 23; Vol. 12 (1), pp. 470. Date of Electronic Publication: 2021 Aug 23.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review
MeSH Terms :
COVID-19*
Idiopathic Pulmonary Fibrosis*/chemically induced
Idiopathic Pulmonary Fibrosis*/therapy
Mesenchymal Stem Cell Transplantation*
Bleomycin/adverse effects ; Humans ; Mesenchymal Stem Cells ; Quality of Life
Czasopismo naukowe
Tytuł :
Fibrotic Idiopathic Interstitial Lung Disease: The Molecular and Cellular Key Players.
Autorzy :
Samarelli AV; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy.
Tonelli R; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy.; Clinical and Experimental Medicine PhD Program, University of Modena Reggio Emilia, 41100 Modena, Italy.
Marchioni A; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy.
Bruzzi G; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy.
Gozzi F; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy.; Clinical and Experimental Medicine PhD Program, University of Modena Reggio Emilia, 41100 Modena, Italy.
Andrisani D; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy.; Clinical and Experimental Medicine PhD Program, University of Modena Reggio Emilia, 41100 Modena, Italy.
Castaniere I; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy.; Clinical and Experimental Medicine PhD Program, University of Modena Reggio Emilia, 41100 Modena, Italy.
Manicardi L; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy.
Moretti A; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy.
Tabbì L; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy.
Cerri S; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy.
Beghè B; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy.
Dominici M; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Oncology Unit, University Hospital of Modena, University of Modena and Reggio Emilia, 41100 Modena, Italy.
Clini E; Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.; Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena Reggio Emilia, 41100 Modena, Italy.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Aug 19; Vol. 22 (16). Date of Electronic Publication: 2021 Aug 19.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Gene Expression Regulation*
Biomarkers/*metabolism
Idiopathic Pulmonary Fibrosis/*pathology
Lung Diseases, Interstitial/*pathology
Animals ; Humans ; Idiopathic Pulmonary Fibrosis/genetics ; Idiopathic Pulmonary Fibrosis/metabolism ; Lung Diseases, Interstitial/genetics ; Lung Diseases, Interstitial/metabolism
Czasopismo naukowe
Tytuł :
Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling.
Autorzy :
Cheng D; Department of Occupational Medical and Environmental Health, Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, China.
Xu Q; Department of Occupational Medical and Environmental Health, Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, China.
Wang Y; Department of Occupational Medical and Environmental Health, Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, China.
Li G; Department of Occupational Medical and Environmental Health, Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, China.
Sun W; Department of Occupational Medical and Environmental Health, Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, China.
Ma D; Department of Occupational Medical and Environmental Health, Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, China.
Zhou S; Department of Occupational Medical and Environmental Health, Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, China.
Liu Y; Department of Occupational Medical and Environmental Health, Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, China.
Han L; Institute of Occupational Disease Prevention, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, 210028, China. .
Ni C; Department of Occupational Medical and Environmental Health, Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, China. .
Pokaż więcej
Źródło :
Journal of translational medicine [J Transl Med] 2021 Aug 16; Vol. 19 (1), pp. 349. Date of Electronic Publication: 2021 Aug 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Metformin*/pharmacology
Metformin*/therapeutic use
Pulmonary Fibrosis*/chemically induced
Pulmonary Fibrosis*/drug therapy
AMP-Activated Protein Kinases ; Animals ; Epithelial-Mesenchymal Transition ; Fibroblasts ; Humans ; Lung ; Mice ; Mice, Inbred C57BL ; Silicon Dioxide/toxicity ; Transforming Growth Factor beta1
Czasopismo naukowe
Tytuł :
Coronavirus disease 2019-associated pulmonary fibrosis: clinical findings, pathogenesis, and potential treatment.
Autorzy :
Jiang YL; School of Medicine, Tsinghua University, Beijing 100084, China.
Dai HP; Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, National Center for Respiratory Medicine, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, National Clinical Research Center for Respiratory Disease, Beijing 100029, China.
Wang C; Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, National Center for Respiratory Medicine, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, National Clinical Research Center for Respiratory Disease, Beijing 100029, China.; Tsinghua University-Peking University Joint Center for Life Sciences, Peking Union Medical College, Beijing 100730, China.
Pokaż więcej
Źródło :
Chinese medical journal [Chin Med J (Engl)] 2021 Aug 05; Vol. 134 (15), pp. 1792-1794.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
Idiopathic Pulmonary Fibrosis*
Pulmonary Fibrosis*
Humans ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Kurarinone Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting TGF-β Signaling Pathways.
Autorzy :
Park SJ; Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 30 Yeongudanji-ro, Ochang-eup, Cheongwon-gu, Cheongju, Chungbuk 28116, Korea.
Kim TH; Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 30 Yeongudanji-ro, Ochang-eup, Cheongwon-gu, Cheongju, Chungbuk 28116, Korea.
Lee K; Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 30 Yeongudanji-ro, Ochang-eup, Cheongwon-gu, Cheongju, Chungbuk 28116, Korea.; Department of Biomolecular Science, University of Science & Technology (UST), Daejeon 341113, Korea.
Kang MA; Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 30 Yeongudanji-ro, Ochang-eup, Cheongwon-gu, Cheongju, Chungbuk 28116, Korea.
Jang HJ; Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 30 Yeongudanji-ro, Ochang-eup, Cheongwon-gu, Cheongju, Chungbuk 28116, Korea.
Ryu HW; Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 30 Yeongudanji-ro, Ochang-eup, Cheongwon-gu, Cheongju, Chungbuk 28116, Korea.
Oh SR; Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 30 Yeongudanji-ro, Ochang-eup, Cheongwon-gu, Cheongju, Chungbuk 28116, Korea.; Department of Biomolecular Science, University of Science & Technology (UST), Daejeon 341113, Korea.
Lee HJ; Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 30 Yeongudanji-ro, Ochang-eup, Cheongwon-gu, Cheongju, Chungbuk 28116, Korea.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Aug 04; Vol. 22 (16). Date of Electronic Publication: 2021 Aug 04.
Typ publikacji :
Journal Article
MeSH Terms :
Flavonoids/*therapeutic use
Pulmonary Fibrosis/*drug therapy
Signal Transduction/*drug effects
Transforming Growth Factor beta/*metabolism
Animals ; Bleomycin ; Cell Line ; Epithelial-Mesenchymal Transition ; Flavonoids/pharmacology ; Humans ; Male ; Mice, Inbred BALB C ; Pulmonary Fibrosis/chemically induced ; Pulmonary Fibrosis/metabolism ; Pulmonary Fibrosis/pathology
Czasopismo naukowe
Tytuł :
Clioquinol Attenuates Pulmonary Fibrosis through Inactivation of Fibroblasts via Iron Chelation.
Autorzy :
Zhu Y; Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology of Hebei Province, College of Life Sciences, Hebei Normal University, Shijiazhuang, Hebei, China.
Chang J; Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology of Hebei Province, College of Life Sciences, Hebei Normal University, Shijiazhuang, Hebei, China.
Tan K; Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology of Hebei Province, College of Life Sciences, Hebei Normal University, Shijiazhuang, Hebei, China.
Huang SK; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, University of Michigan, Ann Arbor, Michigan; and.
Liu X; Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology of Hebei Province, College of Life Sciences, Hebei Normal University, Shijiazhuang, Hebei, China.
Wang X; Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology of Hebei Province, College of Life Sciences, Hebei Normal University, Shijiazhuang, Hebei, China.
Cao M; Department of Respiratory and Critical Care Medicine, Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China.
Zhang H; Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology of Hebei Province, College of Life Sciences, Hebei Normal University, Shijiazhuang, Hebei, China.
Li S; Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology of Hebei Province, College of Life Sciences, Hebei Normal University, Shijiazhuang, Hebei, China.
Duan X; Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology of Hebei Province, College of Life Sciences, Hebei Normal University, Shijiazhuang, Hebei, China.
Chang Y; Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology of Hebei Province, College of Life Sciences, Hebei Normal University, Shijiazhuang, Hebei, China.
Fan Y; Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology of Hebei Province, College of Life Sciences, Hebei Normal University, Shijiazhuang, Hebei, China.
Cao P; Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology of Hebei Province, College of Life Sciences, Hebei Normal University, Shijiazhuang, Hebei, China.
Pokaż więcej
Źródło :
American journal of respiratory cell and molecular biology [Am J Respir Cell Mol Biol] 2021 Aug; Vol. 65 (2), pp. 189-200.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Chelating Agents/*pharmacology
Clioquinol/*pharmacology
Fibroblasts/*metabolism
Idiopathic Pulmonary Fibrosis/*metabolism
Iron/*metabolism
Animals ; Bleomycin/adverse effects ; Bleomycin/pharmacology ; Disease Models, Animal ; Female ; Fibroblasts/pathology ; Humans ; Idiopathic Pulmonary Fibrosis/chemically induced ; Idiopathic Pulmonary Fibrosis/drug therapy ; Idiopathic Pulmonary Fibrosis/pathology ; Male ; Mice
Czasopismo naukowe
Tytuł :
CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
Autorzy :
Tsoyi K; Section of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, Texas.
Liang X; Section of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, Texas.
De Rossi G; William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Ryter SW; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York.
Xiong K; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; and.
Chu SG; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; and.
Liu X; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; and.
Ith B; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; and.
Celada LJ; Section of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, Texas.
Romero F; Section of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, Texas.
Robertson MJ; Section of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, Texas.
Esposito AJ; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; and.
Poli S; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; and.
El-Chemaly S; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; and.
Perrella MA; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; and.
Shi Y; School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
Whiteford J; William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Rosas IO; Section of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, Texas.; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; and.
Pokaż więcej
Źródło :
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2021 Aug 01; Vol. 204 (3), pp. 312-325.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Fibroblasts/*metabolism
Idiopathic Pulmonary Fibrosis/*genetics
Lung/*metabolism
Animals ; Antibiotics, Antineoplastic/toxicity ; Autophagy/drug effects ; Autophagy/genetics ; Bleomycin/toxicity ; Disease Models, Animal ; Fibroblasts/drug effects ; Fibroblasts/pathology ; Humans ; Idiopathic Pulmonary Fibrosis/metabolism ; Idiopathic Pulmonary Fibrosis/pathology ; In Vitro Techniques ; Lung/drug effects ; Lung/pathology ; Mice ; Mice, Knockout ; NF-kappa B/drug effects ; NF-kappa B/metabolism ; Peptide Fragments/pharmacology ; Phenotype ; Phosphatidylinositol 3-Kinases/drug effects ; Phosphatidylinositol 3-Kinases/metabolism ; Primary Cell Culture ; Proto-Oncogene Proteins c-akt/drug effects ; Proto-Oncogene Proteins c-akt/metabolism ; Receptor-Like Protein Tyrosine Phosphatases, Class 3/genetics ; Receptor-Like Protein Tyrosine Phosphatases, Class 3/metabolism ; Signal Transduction ; Syndecan-2/pharmacology ; TOR Serine-Threonine Kinases/drug effects ; TOR Serine-Threonine Kinases/metabolism
Czasopismo naukowe
Tytuł :
Buccal Hydromorphone Syrup for Managing Dyspnea in Idiopathic Pulmonary Fibrosis.
Autorzy :
Fong S; Division of General Internal Medicine, Department of Medicine, 3158University of Alberta, Edmonton, Alberta, Canada.
Richman-Eisenstat J; Division of Pulmonary Medicine, Department of Medicine, 12357University of Alberta, Edmonton, Alberta, Canada.
Kalluri M; Division of Pulmonary Medicine, Department of Medicine, 12357University of Alberta, Edmonton, Alberta, Canada.
Pokaż więcej
Źródło :
The American journal of hospice & palliative care [Am J Hosp Palliat Care] 2021 Aug; Vol. 38 (8), pp. 1046-1052. Date of Electronic Publication: 2020 Nov 03.
Typ publikacji :
Journal Article
MeSH Terms :
Idiopathic Pulmonary Fibrosis*/complications
Idiopathic Pulmonary Fibrosis*/drug therapy
Lung Diseases, Interstitial*
Dyspnea/drug therapy ; Dyspnea/etiology ; Humans ; Hydromorphone/therapeutic use ; Quality of Life
Czasopismo naukowe
Tytuł :
The impact of SARS-COV2 pandemic on the management oF IPF patients: Our narrative experience.
Autorzy :
Benfante A; Dipartimento Universitario di Promozione Della Salute, Materno Infantile, Medicina Interna e Specialistica di Eccellenza 'G. D'Alessandro' (PROMISE), Division of Respiratory Medicine, 'Paolo Giaccone' University Hospital, University of Palermo; Palermo; Italy. Electronic address: .
Messina R; Dipartimento Universitario di Promozione Della Salute, Materno Infantile, Medicina Interna e Specialistica di Eccellenza 'G. D'Alessandro' (PROMISE), Division of Respiratory Medicine, 'Paolo Giaccone' University Hospital, University of Palermo; Palermo; Italy.
Piccionello I; Dipartimento Universitario di Promozione Della Salute, Materno Infantile, Medicina Interna e Specialistica di Eccellenza 'G. D'Alessandro' (PROMISE), Division of Respiratory Medicine, 'Paolo Giaccone' University Hospital, University of Palermo; Palermo; Italy.
Di Liberti R; Dipartimento Universitario di Promozione Della Salute, Materno Infantile, Medicina Interna e Specialistica di Eccellenza 'G. D'Alessandro' (PROMISE), Division of Respiratory Medicine, 'Paolo Giaccone' University Hospital, University of Palermo; Palermo; Italy.
Principe S; Dipartimento Universitario di Promozione Della Salute, Materno Infantile, Medicina Interna e Specialistica di Eccellenza 'G. D'Alessandro' (PROMISE), Division of Respiratory Medicine, 'Paolo Giaccone' University Hospital, University of Palermo; Palermo; Italy.
Scichilone N; Dipartimento Universitario di Promozione Della Salute, Materno Infantile, Medicina Interna e Specialistica di Eccellenza 'G. D'Alessandro' (PROMISE), Division of Respiratory Medicine, 'Paolo Giaccone' University Hospital, University of Palermo; Palermo; Italy.
Pokaż więcej
Źródło :
Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2021 Aug; Vol. 69, pp. 102038. Date of Electronic Publication: 2021 Jun 24.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
COVID-19*
Idiopathic Pulmonary Fibrosis*/drug therapy
Idiopathic Pulmonary Fibrosis*/epidemiology
Humans ; Pandemics ; Pyridones/therapeutic use ; RNA, Viral ; Retrospective Studies ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
LncRNA MEG3 Involved in NiO NPs-Induced Pulmonary Fibrosis via Regulating TGF-β1-Mediated PI3K/AKT Pathway.
Autorzy :
Zhan H; Department of Toxicology, School of Public Health, Lanzhou University, Lanzhou 730000, China.
Sun X; Institute of Occupational Diseases, Gansu Baoshihua Hospital, Lanzhou 730000, China.
Wang X; Department of Toxicology, School of Public Health, Lanzhou University, Lanzhou 730000, China.
Gao Q; Department of Toxicology, School of Public Health, Lanzhou University, Lanzhou 730000, China.
Yang M; Department of Toxicology, School of Public Health, Lanzhou University, Lanzhou 730000, China.
Liu H; Department of Toxicology, School of Public Health, Lanzhou University, Lanzhou 730000, China.
Zheng J; Department of Toxicology, School of Public Health, Lanzhou University, Lanzhou 730000, China.
Gong X; Department of Toxicology, School of Public Health, Lanzhou University, Lanzhou 730000, China.
Feng S; Institute of Occupational Diseases, Gansu Baoshihua Hospital, Lanzhou 730000, China.
Chang X; Department of Toxicology, School of Public Health, Lanzhou University, Lanzhou 730000, China.
Sun Y; Department of Toxicology, School of Public Health, Lanzhou University, Lanzhou 730000, China.
Pokaż więcej
Źródło :
Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2021 Jul 16; Vol. 182 (1), pp. 120-131.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Pulmonary Fibrosis*/chemically induced
Pulmonary Fibrosis*/genetics
RNA, Long Noncoding*/genetics
Animals ; Humans ; Phosphatidylinositol 3-Kinase ; Phosphatidylinositol 3-Kinases/genetics ; Proto-Oncogene Proteins c-akt ; Rats ; Rats, Wistar ; Transforming Growth Factor beta1/genetics ; Transforming Growth Factors
Czasopismo naukowe
Tytuł :
Pulmonary fibrosis and its related factors in discharged patients with new corona virus pneumonia: a cohort study.
Autorzy :
Li X; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, No. 29, Bulan Road, Longgang district, Shenzhen, 518112, China.
Shen C; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, No. 29, Bulan Road, Longgang district, Shenzhen, 518112, China. .; School of Public Health, Southern Medical University, Guangzhou, 510515, China. .
Wang L; Department of Radiology, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.
Majumder S; EEE Department, Southern University of Science & Technology, China and ECE Department, McMaster Univ., Hamilton, Canada.
Zhang D; Department of Radiology, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.
Deen MJ; EEE Department, Southern University of Science & Technology, China and ECE Department, McMaster Univ., Hamilton, Canada.
Li Y; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, No. 29, Bulan Road, Longgang district, Shenzhen, 518112, China.
Qing L; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, No. 29, Bulan Road, Longgang district, Shenzhen, 518112, China.
Zhang Y; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, No. 29, Bulan Road, Longgang district, Shenzhen, 518112, China.
Chen C; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, No. 29, Bulan Road, Longgang district, Shenzhen, 518112, China.
Zou R; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, No. 29, Bulan Road, Longgang district, Shenzhen, 518112, China.
Lan J; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, No. 29, Bulan Road, Longgang district, Shenzhen, 518112, China.
Huang L; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, No. 29, Bulan Road, Longgang district, Shenzhen, 518112, China.
Peng C; Department of Radiology, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.
Zeng L; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, No. 29, Bulan Road, Longgang district, Shenzhen, 518112, China.
Liang Y; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, No. 29, Bulan Road, Longgang district, Shenzhen, 518112, China.
Cao M; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, No. 29, Bulan Road, Longgang district, Shenzhen, 518112, China.
Yang Y; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, No. 29, Bulan Road, Longgang district, Shenzhen, 518112, China.
Yang M; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, No. 29, Bulan Road, Longgang district, Shenzhen, 518112, China.
Tan G; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, No. 29, Bulan Road, Longgang district, Shenzhen, 518112, China.
Tang S; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, No. 29, Bulan Road, Longgang district, Shenzhen, 518112, China.
Liu L; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, No. 29, Bulan Road, Longgang district, Shenzhen, 518112, China. .
Yuan J; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, No. 29, Bulan Road, Longgang district, Shenzhen, 518112, China. .
Liu Y; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, No. 29, Bulan Road, Longgang district, Shenzhen, 518112, China. .
Pokaż więcej
Źródło :
Respiratory research [Respir Res] 2021 Jul 09; Vol. 22 (1), pp. 203. Date of Electronic Publication: 2021 Jul 09.
Typ publikacji :
Journal Article
MeSH Terms :
Patient Discharge*
COVID-19/*virology
Lung/*virology
Pulmonary Fibrosis/*virology
SARS-CoV-2/*pathogenicity
Adolescent ; Adult ; COVID-19/complications ; COVID-19/diagnosis ; China ; Female ; Host-Pathogen Interactions ; Humans ; Lung/diagnostic imaging ; Lung/physiopathology ; Male ; Middle Aged ; Prognosis ; Pulmonary Fibrosis/diagnostic imaging ; Pulmonary Fibrosis/physiopathology ; Respiratory Function Tests ; Time Factors ; Tomography, X-Ray Computed ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies